Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 140,428,848
  • Shares Outstanding, K 1,478,821
  • Annual Sales, $ 33,266 M
  • Annual Income, $ 7,882 M
  • 60-Month Beta 0.96
  • Price/Sales 4.19
  • Price/Cash Flow 10.09
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 2.25
  • Number of Estimates 3
  • High Estimate 2.31
  • Low Estimate 2.15
  • Prior Year 2.14
  • Growth Rate Est. (year over year) +5.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.41 +18.09%
on 01/31/20
97.86 -2.96%
on 02/12/20
+6.97 (+7.92%)
since 01/21/20
3-Month
80.41 +18.09%
on 01/31/20
97.86 -2.96%
on 02/12/20
+8.44 (+9.75%)
since 11/21/19
52-Week
62.66 +51.55%
on 08/15/19
97.86 -2.96%
on 02/12/20
+16.21 (+20.58%)
since 02/21/19

Most Recent Stories

More News
Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS

Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS

CVX : 109.01 (-0.73%)
CVS : 71.51 (-0.60%)
AGN : 200.15 (+0.71%)
OXY : 42.12 (-1.98%)
ABBV : 94.96 (+0.77%)
AbbVie Declares Quarterly Dividend

The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.

ABBV : 94.96 (+0.77%)
One of Your Stock Investments is Being Acquired: Now What?

One of your companies gets a buyout offer and the shares soar. There might be different strategies for traders and investors on what to do next.

CVX : 109.01 (-0.73%)
CVS : 71.51 (-0.60%)
AGN : 200.15 (+0.71%)
OXY : 42.12 (-1.98%)
ABBV : 94.96 (+0.77%)
Signs That Your Trading Will Ruin Your Retirement - February 20, 2020

Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.

ABBV : 94.96 (+0.77%)
DRI : 121.10 (+0.35%)
FDEF : 28.16 (+0.11%)
Easy Investing Secrets to an Early Retirement - February 19, 2020

Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments,...

DRI : 121.10 (+0.35%)
BMY : 65.63 (+0.71%)
ABBV : 94.96 (+0.77%)
AbbVie to Present at the Cowen 40th Annual Health Care Conference

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Cowen 40th Annual Health Care Conference on Wednesday, March 4, 2020. Michael Severino, M.D., vice chairman...

ABBV : 94.96 (+0.77%)
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue

In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of February 17, 2020 its issued share capital, excluding treasury shares, is comprised...

ABBV : 94.96 (+0.77%)
Myasthenia Gravis Treatment Market: Global Industry Analysis and Opportunity Assessment 2019-2025

Myasthenia Gravis Treatment Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate...

ABBV : 94.96 (+0.77%)
GSK : 43.08 (+0.75%)
NVS : 96.76 (+0.49%)
TEVA : 13.19 (-0.90%)
VRX.TO : 30.80 (-3.33%)
SHAREHOLDER ALERT: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers of AbbVie Inc. - ABBV

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors...

ABBV : 94.96 (+0.77%)
ImmunoGen (IMGN) Q4 Earnings & Sales Beat, Shares Rally

ImmunoGen (IMGN) reports fourth-quarter results with earnings and revenues beating estimates.

RHHBY : 44.0300 (+0.39%)
JAZZ : 134.82 (-0.50%)
IMGN : 5.41 (-3.05%)
ABBV : 94.96 (+0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ABBV with:

Business Summary

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation...

See More

Key Turning Points

2nd Resistance Point 96.76
1st Resistance Point 95.86
Last Price 94.96
1st Support Level 93.72
2nd Support Level 92.48

See More

52-Week High 97.86
Last Price 94.96
Fibonacci 61.8% 84.41
Fibonacci 50% 80.26
Fibonacci 38.2% 76.11
52-Week Low 62.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar